RB loses final Nurofen appeal in High Court

It must pay the $6 million penalty for making misleading representations about its Nurofen Specific Pain products A final High Court appeal by Reckitt Benckiser against a penalty imposed for contravening the Australian Consumer Law has been rejected this week, Fairfax reports. The initial $1.7 million penalty handed down by the Full Court in April

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Forum: Will there be low-dose codeine after 1 Feb 2018?
Next Keeping it private